Evidence map›Paper›PMID 41736435›Full record

Trial reportJournal of traditional Chinese medicine = Chung i tsa chih ying wen pan2026

Effect of point application therapy for bronchial asthma: a multicenter randomized controlled trial.

X U Huanfang, L I Jiashan, Yang Li, W U Wenzhong, Yang Jun, Zhang Wei, L I Hui, Q U Nini, Wang Rui, Wang Landi and 6 more

Abstract readRandomized Controlled TrialMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

X U HuanfangAcupuncture and Moxibustion Hospital, Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing 100700, China.
L I JiashanAcupuncture and Moxibustion Hospital, Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Yang LiAcupuncture and Moxibustion Hospital, Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing 100700, China.
W U WenzhongDepartment of Acupuncture and Moxibustion, Jiangsu Provincial Hospital of Chinese Medicine, Nanjing 210029, China.
Yang JunDepartment of Acupuncture and Moxibustion, the First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, China.
Zhang WeiDepartment of Acupuncture and Moxibustion, the First Hospital of Hunan University of Chinese Medicine, Changsha 410007, China.
L I HuiDepartment of Acupuncture and Moxibustion, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
Q U NiniDepartment of Respiratory Medicine, the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110032, China.
Wang RuiDepartment of Acupuncture and Moxibustion, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.
Wang LandiDepartment of Respiratory Medicine, Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou 730050, China.
Yang HongzhiDepartment of Acupuncture and Moxibustion, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430061, China.
Zhang LihuaDepartment of Acupuncture and Moxibustion, Shaanxi Provincial Hospital of Traditional Chinese Medicine, Xi'an 710003, China.
H E YongDepartment of Respiratory Medicine, Zhengzhou Hospital of Traditional Chinese Medicine, Zhengzhou 450007, China.
Xiong GuanyuDepartment of Acupuncture and Moxibustion, Kaifeng Hospital of Traditional Chinese Medicine, Kaifeng 475000, China.
Liu BaoyanDepartment of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Fang YigongAcupuncture and Moxibustion Hospital, Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing 100700, China.

Funding

"12th Five-year" National Science and Technology Pillar Program by the Ministry of Science and Technology of the People's Republic of China: Clinical Evaluation and Technical Operation Specification Research on Preventing Bronchial Asthma Attacks by Acupoint Application in Winter Disease Summer Treatment 2015BAI04B11
6 · The paper itself

Abstract

objectiveTo assess the efficacy of point application therapy (PAT) in alleviating the exacerbation of chronic respiratory diseases represented by bronchial asthma.

methodsIn this multicenter randomized placebo-controlled trial, eligible bronchial asthma patients received placebo PAT on the dog days of the first summer to establish a baseline, and then patients who continued to participate in the trial and repassed the eligibility review were randomized to receive regular or placebo PAT in the next two consecutive summers. The primary outcome was the change from baseline in the number of asthma exacerbations at 24 months. Secondary outcomes included severity of asthma exacerbation, asthma control test (ACT) score, percentage of forced expiratory volume in 1 s (FEV

resultsA total of 835 patients with bronchial asthma were randomized in this trial. Compared with the placebo control, the PAT significantly decreased the mean number of asthma exacerbations (1.42; 95% confidence interval, 0.69 to 2.14;

conclusionPAT conducted on dog days could reduce asthma exacerbations in patients with bronchial asthma.

Indexed as

AsthmaDrugs, Chinese HerbalAdolescentAdultAgedFemaleForced Expiratory VolumeHumansMaleMiddle AgedTreatment OutcomeYoung AdultDrugs, Chinese Herbalasthmanumber of asthma exacerbationspoint application therapyrandomized controlled trial

Identifiers

PMID41736435
PMCPMC12884504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.